Amicus Therapeutics – Striving to Give Solutions to Rare and Devastating Diseases

Amicus Therapeutics is New Jersey-based biotechnology company dealing with coming up with therapies to treat rare or orphan diseases. The company uses a unique combination of technologies and medications to ensure people living with rare and devastating diseases are cured. Such conditions include Pompe disease, Lysosomal Storage Disorders Fabry, and Epidermolysis Bullosa (http://releasefact.com/2017/08/amicus-therapeutics-funds-its-ground-breaking-new-treatment/). To treat …

Who is Mark Holterman?

Dr. Mark Holterman is a pediatric and surgical professor at the University of Illinois college of medicine. Mark holds board positions with several medical organizations and positions. He is very experienced in his field of study, he has over two decades of experience in pediatric surgery and medicine.   Dr. Mark Holterman is also the …